FDA
-
-
-
-
-
-
-
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results
-
-
-
-
-
-
-
Pulse Biosciences enrolls first patient in cardiac surgery study
-
-
-
-
-
-
-
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting
-
-
-
-
-
-
-
Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association
-
-
-
-
-
-
-
Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System
-
-
-
-
-
-
-
Pulse Biosciences (PLSE) Announces First-in-Human Procedures with its Novel CellFX Nanosecond Pulsed Field Ablation Cardiac Catheter
-
-
-
-
-
-
-
Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results
-
336,084 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


